CSIMarket


Orphazyme A  (ORPH)
Other Ticker:  
 

Orphazyme A

ORPH's Fundamental analysis








Looking into Orphazyme A growth rates, revenue grew in IV. Quarter 2021 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 29.91 %

Orphazyme A net loss deacreased by in IV. Quarter 2021 year on year, Orphazyme A net loss increased by -1.06 % in IV. Quarter 2021 year on year,

More on ORPH's Growth


Orphazyme A
reported net loss of -627 millions in the past twelve months.

Company is currently trading with Price to Cash flow multiple of 0.25 in trailing twelve-month period.
Company